A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial is a research paper published in European Journal of Heart Failure (2021). On theSindex it has a DataRank of 0. It has been cited 166 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: U01 HL087366
NHLBI NIH HHS
Grant: F32 HL139046
NHLBI NIH HHS
Grant: UM1 HL087365
NHLBI NIH HHS
Grant: U01 HL087394
NHLBI NIH HHS
Grant: UM1 HL113530
NHLBI NIH HHS
Grant: U01 HL087365
NHLBI NIH HHS
Grant: UM1 HL113460
NHLBI NIH HHS
Grant: U01 HL087318
NHLBI NIH HHS
Grant: UM1 HL087318
NHLBI NIH HHS
Grant: UM1 HL087366
NHLBI NIH HHS
Grant: UM1 HL087394
NHLBI NIH HHS
Grant: UM1 HL113457
National Institutes of Health
Grant: 2UM1HL087394-06
MN Regional Cardiovascular Cell Therapy Clinical Res. Network: From AMI to PAD
National Institutes of Health
Grant: 5UM1HL113530-06
University of Louisville Regional Clinical Center for the CCTRN
National Institutes of Health
Grant: 3U01HL087318-02S1
Cardiovascular Cell Therapy Research Network - Data Coordinating Center
National Institutes of Health
Grant: 4UM1HL113460-05
Cell Based Therapy for Non-Ischemic Dilated Cardiomyopathy
National Institutes of Health
Grant: 3UM1HL087365-10S1
Cardiovascular Cell Therapy Research Network
National Institutes of Health
Grant: 5UM1HL087366-08
UFRCC for Cardiovascular Cell Therapy Research Network
National Institutes of Health
FWCI
14.55
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals